Endocrine Abstracts

Contents

• 16th Annual Meeting of the UK and Ireland Neuroendocrine Tumour Society 2018
• • Speaker Abstracts
  • Diagnostic and Management Challenges in NETs
  • • New pathology classification in GEP-NENs

      ea0060nets1
    • Chemotherapy:“is this the end of an old friend”

      ea0060nets2
    • Medullary thyroid carcinoma: management challenges

      ea0060nets3
    • Duodenal NETs: under (-over) treated?

      ea0060nets4
    • Nutrition support in GEP-NETs: an underestimated co-worker

      ea0060nets5
  • Bronchial NETs
  • • Abstract unavailable

      ea0060nets6
    • Abstract unavailable

      ea0060nets7
    • Abstract unavailable

      ea0060nets8
    • Abstract unavailable

      ea0060nets9
    • Surgical management of thoracic neuroendocrine tumours

      ea0060nets10
    • Bronchial NETs: follow-up pathways: A lung physicians view

      ea0060nets11
    • Bronchial NETs

      ea0060nets12
  • Challenging the Experts
  • • Abstract unavailable

      ea0060nets13
    • Abstract unavailable

      ea0060nets14
    • Abstract unavailable

      ea0060nets15
    • Abstract unavailable

      ea0060nets16
    • Abstract unavailable

      ea0060nets17
    • Abstract unavailable

      ea0060nets18
    • Abstract unavailable

      ea0060nets19
  • Translational Science
  • • Immunotherapy in NETs

      ea0060nets20
  • Plenary Speaker
  • • Abstract unavailable

      ea0060nets21
• Oral Communications
• • (1)
  • • The proinflammatory molecule, VAP-1, is enriched in the stroma of midgut NETs and plaques of carcinoid heart disease valves

      ea0060oc1
    • Lanreotide depot/autogel before, during, and after peptide receptor radionuclide therapy (PRRT) in advanced neuroendocrine tumors (NETs): Data from the PRELUDE study

      ea0060oc2
    • PUnNETS (Prediction of Unknown Neuroendocrine Tumour Site) - a DNA methylation-based classifier

      ea0060oc3
• Poster Presentations
• • (1)
  • • Functional or non-function pancreatic NET; Novel use of a flash glucose monitoring system

      ea0060p01
    • Overview of neuroendocrine patient demographics and outcomes in the Leicestershire region

      ea0060p02
    • Second primary malignancies (SPMs) in patients with non-pulmonary well-differentiated neuroendocrine tumours (wdNETs)

      ea0060p03
    • A case series of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia

      ea0060p04
    • Problematic bronchial carcinoid

      ea0060p05
    • Identifying information and support needs for patients with Merkel Cell Carcinoma

      ea0060p06
    • Bone metastases (BMs) in patients with neuroendocrine neoplasms (NENs): Prevalence and clinical management in a tertiary cancer centre

      ea0060p07
    • Periodic endoscopic surveillance in patients with low risk type I gastric neuroendocrine tumours (gNETs) also detects associated gastric adenocarcinoma in a subset of patients

      ea0060p08
    • Lesson learnt: severe skin reaction to somatostatin analogue injections

      ea0060p09
    • Everolimus - associated grade 4 pneumonitis: a case report and literature discussion

      ea0060p10
    • Nutritional status of patients at diagnosis with a bronchial NET

      ea0060p11
    • Glenfield Pulmonary Neuroendocrine Guidelines

      ea0060p12
    • Automated finger prick genomic diagnosis of neuroendocrine tumors

      ea0060p13
    • Circulating neuroendocrine tumor gene expression is effective in monitoring peptide receptor radionuclide (PRRT) efficacy

      ea0060p14
    • NETest liquid biopsy is diagnostic of lung neuroendocrine tumors and identifies progressive disease

      ea0060p15
    • Validation of the NETest liquid biopsy as a diagnostic for gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

      ea0060p16
    • Use of choline PET-CT in the diagnosis of neuroendocrine tumours

      ea0060p17
    • The impact of 68Ga-based PET-CT scanning on the management of patients with sporadic pancreatic neuroendocrine tumours (pNETs)

      ea0060p18
    • Imaging in paragangliomas and phaeochromocytomas: a pictorial review

      ea0060p19
    • Chest metastases in advanced small bowel neuroendocrine neoplasms: incidence and outcome

      ea0060p20
    • Utility of PRRT therapy in invasive intra-cardiac paraganglioma

      ea0060p21
    • Seeking the unseen: a case of occult sporadic insulinoma: localization, surgical strategy: a rare case

      ea0060p23
    • Assessment of fat-soluble vitamins and trace elements in neuroendocrine tumour (NET) patients on somatostatin analogues

      ea0060p24
    • Tumour growth rate (TGR) in neuroendocrine tumours (NETs): changes following systemic treatment and external validation of previous findings; the GREPONET-2 study

      ea0060p26
    • Unmasking ectopic ACTH secretion and changing functionality of a pulmonary neuroendocrine tumour with carcinoid syndrome

      ea0060p27
    • Bronchial carcinoid presenting in young adults. A case series highlighting issues in disease management, unusual sites of metastases and long term surveillance

      ea0060p28
    • The role of imaging in neuroendocrine tumours

      ea0060p29
    • The impact of 68Ga-based PET-CT scanning on the management of patients with familial pancreatic neuroendocrine tumours (panNETs)

      ea0060p30